Technology markets are changing fast. This brief identifies and tracks the key forces shaping the prospects for your business. In this piece, Datamonitor's analyst specializing in pharmaceutical technology will outline the changes in the market, explain which trends will have the biggest impact, and highlight who will benefit from the fast-paced developments in pharmaceutical technology.

Scope

An overview of the challenges facing the life science industry in 2008 Datamonitor's take on the technology priorities of pharmaceutical and biotechnology companies Strategies to help technology vendors penetrate the life science industry

Highlights

As the specter of generic competition grows, streamlining operations to reduce costs and time-to-market of a drug will be a top priority for pharmaceutical companies. The life science industry must embrace technology solutions as it shifts away from the "blockbuster drug" business model. Data management is a key issue affecting the life sciences. As drug regulatory agencies demand more clinical and post-market data, clinical IT solutions will become crucial to the industry.

Reasons to Purchase

Learn about the top trends in the life science industry in 2008 Identify strategies for expanding business opportunities in the life science industry Tailor your go-to-market strategy to address critical issues facing pharmaceutical and biotechnology companies.